An Essential Role for Liver ERα in Coupling Hepatic Metabolism to the Reproductive Cycle.

PubWeight™: 0.79‹?›

🔗 View Article (PMID 27050513)

Published in Cell Rep on March 31, 2016

Authors

Sara Della Torre1, Nico Mitro2, Roberta Fontana3, Monica Gomaraschi2, Elda Favari4, Camilla Recordati5, Federica Lolli1, Fabiana Quagliarini6, Clara Meda1, Claes Ohlsson7, Maurizio Crestani2, Nina Henriette Uhlenhaut6, Laura Calabresi2, Adriana Maggi8

Author Affiliations

1: Center of Excellence on Neurodegenerative Diseases, University of Milan, 20133 Milan, Italy; Department of Pharmacological and Biomolecular Sciences, University of Milan, 20133 Milan, Italy.
2: Department of Pharmacological and Biomolecular Sciences, University of Milan, 20133 Milan, Italy.
3: Department of Pharmacological and Biomolecular Sciences, University of Milan, 20133 Milan, Italy; Department of Drug Discovery and Development, Italian Institute of Technology, 16163 Genova, Italy.
4: Department of Pharmacy, University of Parma, 43121 Parma, Italy.
5: Mouse and Animal Pathology Laboratory, Fondazione Filarete, 20139 Milan, Italy.
6: Helmholtz Diabetes Center (HDC) and German Center for Diabetes Research (DZD), Helmholtz Zentrum Muenchen, 85764 Munich-Neuherberg, Germany.
7: Centre for Bone and Arthritis Research and Department of Internal Medicine and Clinical Nutrition, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, 40530 Gothenburg, Sweden.
8: Center of Excellence on Neurodegenerative Diseases, University of Milan, 20133 Milan, Italy; Department of Pharmacological and Biomolecular Sciences, University of Milan, 20133 Milan, Italy. Electronic address: adriana.maggi@unimi.it.

Articles cited by this

HDL cholesterol efflux capacity and incident cardiovascular events. N Engl J Med (2014) 8.61

Direct and indirect mechanisms for regulation of fatty acid synthase gene expression by liver X receptors. J Biol Chem (2002) 3.58

In vivo imaging of transcriptionally active estrogen receptors. Nat Med (2002) 2.50

Increased hepatic synthesis and dysregulation of cholesterol metabolism is associated with the severity of nonalcoholic fatty liver disease. Cell Metab (2012) 1.97

Risk factors for coronary heart disease: implications of gender. Cardiovasc Res (2002) 1.87

Genome-wide profiling of liver X receptor, retinoid X receptor, and peroxisome proliferator-activated receptor α in mouse liver reveals extensive sharing of binding sites. Mol Cell Biol (2011) 1.77

PPAR- and LXR-dependent pathways controlling lipid metabolism and the development of atherosclerosis. J Lipid Res (2004) 1.70

Insights into negative regulation by the glucocorticoid receptor from genome-wide profiling of inflammatory cistromes. Mol Cell (2012) 1.51

Genome-wide identification of estrogen receptor alpha-binding sites in mouse liver. Mol Endocrinol (2007) 1.50

Liver LXRα expression is crucial for whole body cholesterol homeostasis and reverse cholesterol transport in mice. J Clin Invest (2012) 1.38

Minireview: the year in review of estrogen regulation of metabolism. Mol Endocrinol (2012) 1.22

Prevalence of non alcoholic fatty liver disease in premenopausal, posmenopausal and polycystic ovary syndrome women. The role of estrogens. Ann Hepatol (2010) 1.21

PPARs: transcription factors controlling lipid and lipoprotein metabolism. Ann N Y Acad Sci (2002) 1.10

Amino acid-dependent activation of liver estrogen receptor alpha integrates metabolic and reproductive functions via IGF-1. Cell Metab (2011) 1.10

Prevalence of nonalcoholic fatty liver disease in women with polycystic ovary syndrome. Clin Gastroenterol Hepatol (2007) 1.03

Estrogen and related compounds: biphasic dose responses. Crit Rev Toxicol (2001) 1.01

Non-monotonic dose-response relationship in steroid hormone receptor-mediated gene expression. J Mol Endocrinol (2007) 0.99

Estrogen receptor ligands ameliorate fatty liver through a nonclassical estrogen receptor/Liver X receptor pathway in mice. Hepatology (2014) 0.99

Estrogen receptor-mediated repression of human hepatic lipase gene transcription. J Lipid Res (2002) 0.98

Animal models for the atherosclerosis research: a review. Protein Cell (2011) 0.94

Regulation of high-density lipoprotein metabolism. Circ Res (2014) 0.91

Excess visceral and hepatic adipose tissue in Turner syndrome determined by magnetic resonance imaging: estrogen deficiency associated with hepatic adipose content. J Clin Endocrinol Metab (2005) 0.90

Energy metabolism and fertility: a balance preserved for female health. Nat Rev Endocrinol (2013) 0.90

Oral estrogen replacement therapy in postmenopausal women selectively raises levels and production rates of lipoprotein A-I and lowers hepatic lipase activity without lowering the fractional catabolic rate. Arterioscler Thromb Vasc Biol (1996) 0.89

ApoM: gene regulation and effects on HDL metabolism. Trends Endocrinol Metab (2009) 0.86

Estrogenic activities in rodent estrogen-free diets. Endocrinology (2005) 0.85

Responses of HDL subclasses, Lp(A-I) and Lp(A-I:A-II) levels and lipolytic enzyme activities to continuous oral estrogen-progestin and transdermal estrogen with cyclic progestin regimens in postmenopausal women. Atherosclerosis (1997) 0.83

Hepatic VLDL-TG production and MTP gene expression are decreased in ovariectomized rats: effects of exercise training. Horm Metab Res (2010) 0.83

Structural basis for distinct functions of the naturally occurring Cys mutants of human apolipoprotein A-I. J Lipid Res (2013) 0.82

Emerging role of cellular cholesterol in the pathogenesis of nonalcoholic fatty liver disease. Curr Opin Lipidol (2013) 0.81

Estrogen upregulates hepatic apolipoprotein M expression via the estrogen receptor. Biochim Biophys Acta (2011) 0.80

ABCA1-dependent serum cholesterol efflux capacity inversely correlates with pulse wave velocity in healthy subjects. J Lipid Res (2012) 0.78